Immunotherapy prototype Mark 3.0 model in primary liver cancer: adding locoregional stereotactic therapy and prognostic factors classification management (English)
Free access
- New search for: Yang, Xu
- New search for: Zhang, Nan
- New search for: Song, Yang
- New search for: Yang, Xiaobo
- New search for: Sang, Xinting
- New search for: Zhao, Haitao
- Further information on Zhao, Haitao:
- https://orcid.org/0000-0002-3444-8044
- New search for: Yang, Xu
- New search for: Zhang, Nan
- New search for: Song, Yang
- New search for: Yang, Xiaobo
- New search for: Sang, Xinting
- New search for: Zhao, Haitao
- Further information on Zhao, Haitao:
- https://orcid.org/0000-0002-3444-8044
In:
Medical Review
;
2
, 6
;
547-552
;
2023
-
ISSN:
- Article (Journal) / Electronic Resource
-
Title:Immunotherapy prototype Mark 3.0 model in primary liver cancer: adding locoregional stereotactic therapy and prognostic factors classification management
-
Contributors:Yang, Xu ( author ) / Zhang, Nan ( author ) / Song, Yang ( author ) / Yang, Xiaobo ( author ) / Sang, Xinting ( author ) / Zhao, Haitao ( author )
-
Published in:Medical Review ; 2, 6 ; 547-552
-
Publisher:
- New search for: De Gruyter
-
Publication date:2023-02-10
-
Size:06 pages
-
ISSN:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:English
-
Keywords:
-
Licence:
-
Source:
Table of contents – Volume 2, Issue 6
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 541
-
Precision medicine revolutionizes cancer diagnosis and treatmentHan, Chuanhui / Zhan, Qimin et al. | 2023
- 544
-
Tumorigenesis from non-alcoholic steatohepatitis to hepatocellular carcinomaYu, Junjie / Pajvani, Utpal B. et al. | 2023
- 547
-
Immunotherapy prototype Mark 3.0 model in primary liver cancer: adding locoregional stereotactic therapy and prognostic factors classification managementYang, Xu / Zhang, Nan / Song, Yang / Yang, Xiaobo / Sang, Xinting / Zhao, Haitao et al. | 2023
- 553
-
Precision intervention of cell type-specific targeting is required for future cancer immunotherapyCai, Yitong / Zhang, Anli / Lu, Changzheng et al. | 2023
- 555
-
Therapeutic antibodies for precise cancer immunotherapy: current and future perspectivesLiu, Longchao / Chen, Jiahui et al. | 2023
- 570
-
Understanding recurrent pregnancy loss: recent advances on its etiology, clinical diagnosis, and managementCao, Chunwei / Bai, Shiyu / Zhang, Jing / Sun, Xiaoyue / Meng, Anming / Chen, Hui et al. | 2023
- 590
-
Ovarian aging: mechanisms and intervention strategiesZhu, Zhengmao / Xu, Wanxue / Liu, Lin et al. | 2023
- 611
-
Atypical functions of xenobiotic receptors in lipid and glucose metabolismWang, Jingyuan / Lu, Peipei / Xie, Wen et al. | 2023
- i
-
Frontmatter| 2023